David V. Batchelor

An Imidazopiperidine Series of CCR5 Antagonists for the Treatment of HIV: The Discovery of <i>N</i>-{(1<i>S</i>)-1-(3-Fluorophenyl)-3-[(3-<i>endo</i>)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]propyl}acetamide (PF-232798)

Paul A. Stupple, David V. Batchelor, Martin Corless et al. · Journal of Medicinal Chemistry · 2010 · 40 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

SAR of a series of inhaled A2A agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data

Simon J. Mantell, Peter T. Stephenson, Sandra M. Monaghan et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 24 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Inhaled adenosine A2A receptor agonists for the treatment of chronic obstructive pulmonary disease

Simon J. Mantell, Peter T. Stephenson, Sandra M. Monaghan et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 23 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Design and synthesis of a functionally selective D3 agonist and its in vivo delivery via the intranasal route

Julian Blagg, Charlotte Allerton, David V. Batchelor et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 16 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +15

A Convenient Synthesis of HighlySubstituted 3-<i>N</i>,<i>N</i>-Dialkylamino-1,2,4-triazoles

Simon Wheeler, David V. Batchelor, David M. Beal et al. · Synlett · 2008 · 10 citations

Natural Sciences, Chemistry, Medicinal Chemistry +10